We are live on ! Find out more
IMA

ImageneBio Inc

46 hedge funds and large institutions have $106M invested in ImageneBio Inc in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

0.17% less ownership

Funds ownership: 6.34%6.17% (-0.17%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

4% less funds holding

Funds holding: 4846 (-2)

37% less capital invested

Capital invested by funds: $168M → $106M (-$62.1M)

68% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 19

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
14
Increased
6
Reduced
19
Closed
15
Calls
Puts
Net Calls
Net Calls Change

IMA Hedge Fund Activity: Q2 2022 in Review

46 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2022, worth a combined $106M — down 37% from $168M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IMA and 14 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 6 added.

The largest buyer was Verition Fund Management, opening a new position worth an estimated $4.7M. The largest seller was BlackRock, cutting an estimated $5.54M.

  • 46 institutional investors held ImageneBio Inc (IMA) as of Q2 2022, down from 48 in Q1 2022.
  • Funds reported $106M of ImageneBio Inc stock for Q2 2022, down 37% quarter-over-quarter.
  • 14 funds opened new ImageneBio Inc positions in Q2 2022 and 15 closed out, a net change of -1 holder.
  • The largest ImageneBio Inc buyer in Q2 2022 was Verition Fund Management, an estimated $4.7M added.
  • The largest ImageneBio Inc seller in Q2 2022 was BlackRock, an estimated $5.54M sold.

Based on aggregated 13F filings for Q2 2022.